cas 1240390-28-6|| where to buy 2,4-Dichloropyrimidine-5-carboxamide

Название продукции:2,4-Dichloropyrimidine-5-carboxamide

IUPAC Name:2,4-dichloropyrimidine-5-carboxamide

: CAS：1240390-28-6; Молекулярная формула：C5H3Cl2N3O; Чистота：97%

Упаковочная единица	Доступно для заказа	Цена ($)
CM167387-5g	in stock	ŔŢ
CM167387-10g	in stock	ŢƄǯ
CM167387-25g	in stock	źŢư

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1240390-28-6 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

: Номер CAS:1240390-28-6; Молекулярная формула:C5H3Cl2N3O; Точка плавления:-; Smiles-код:O=C(C1=CN=C(Cl)N=C1Cl)N; Плотность:

: Номер в каталоге:CM167387; Молекулярная масса:192; Точка кипения:; Номер Mdl:MFCD16658133; Хранение:Keep in dark place, inert atmosphere, store at 2-8°C.

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

: Cerdulatinib; Cerdulatinib is a small molecule SYK/JAK kinase inhibitor in development for treatment of hematological malignancies. It has lowest nM IC50 values against TYK2, JAK1, JAK2, JAK3, FMS, and SYK. Cerdulatinib is a reversible ATP-competitive dual JAK and Syk inhibitor. The FDA granted orphan drug status to cerdulatinib for the treatment of peripheral T-cell lymphoma (PTCL).